Prophylaxis of thrombosis
US11078297B2 · kind B2 · utility
0Cited by
6References
10Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Dec 21, 2015 |
| Grant date | Aug 3, 2021 |
| Priority date | — |
| Expiry date | Apr 7, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/505
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides a method and composition for preventing thrombosis and complications associated therewith by targeting Sf2 directly. The invention provides Sf2-deficiency or prophylactic administration of a therapeutic agent, such as a Sf2 antagonist or a Sf2 antibody, markedly reduces thrombus formation that would otherwise be caused due to surgery, immobility, genetic abnormality, cancer, trauma, or other risk factors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.